{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:54:23Z","timestamp":1793213663210,"version":"4.5.0"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi230195-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The prevalence and baseline risk factors of post\u2013COVID-19 condition (PCC) remain unresolved among the large number of young people who experienced mild COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230195-5\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the point prevalence of PCC 6 months after the acute infection, to determine the risk of development of PCC adjusted for possible confounders, and to explore a broad range of potential risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230195-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cohort study included nonhospitalized individuals from 2 counties in Norway between ages 12 and 25 years who underwent reverse transcription\u2013polymerase chain reaction (RT-PCR) testing. At the early convalescent stage and at 6-month follow-up, participants underwent a clinical examination; pulmonary, cardiac, and cognitive functional testing; immunological and organ injury biomarker analyses; and completion of a questionnaire. Participants were classified according to the World Health Organization case definition of PCC at follow-up. Association analyses of 78 potential risk factors were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230195-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>SARS-CoV-2 infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230195-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The point prevalence of PCC 6 months after RT-PCR testing in the SARS-CoV-2\u2013positive and SARS-CoV-2\u2013negative groups, and the risk difference with corresponding 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230195-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 404 individuals testing positive for SARS-CoV-2 and 105 individuals testing negative were enrolled (194 male [38.1%]; 102 non-European [20.0%] ethnicity). A total of 22 of the SARS-CoV-2\u2013positive and 4 of the SARS-CoV-2\u2013negative individuals were lost to follow-up, and 16 SARS-CoV-2\u2013negative individuals were excluded due to SARS-CoV-2 infection in the observational period. Hence, 382 SARS-CoV-2\u2013positive participants (mean [SD] age, 18.0 [3.7] years; 152 male [39.8%]) and 85 SARS-CoV-2\u2013negative participants (mean [SD] age, 17.7 [3.2] years; 31 male [36.5%]) could be evaluated. The point prevalence of PCC at 6 months was 48.5% in the SARS-CoV-2\u2013positive group and 47.1% in the control group (risk difference, 1.5%; 95% CI, \u221210.2% to 13.1%). SARS-CoV-2 positivity was not associated with the development of PCC (relative risk [RR], 1.06; 95% CI, 0.83 to 1.37; final multivariable model utilizing modified Poisson regression). The main risk factor for PCC was symptom severity at baseline (RR, 1.41; 95% CI, 1.27-1.56). Low physical activity (RR, 0.96; 95% CI, 0.92-1.00) and loneliness (RR, 1.01; 95% CI, 1.00-1.02) were also associated, while biological markers were not. Symptom severity correlated with personality traits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi230195-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>The persistent symptoms and disability that characterize PCC are associated with factors other than SARS-CoV-2 infection, including psychosocial factors. This finding raises questions about the utility of the World Health Organization case definition and has implications for the planning of health care services as well as for further research on PCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.5763","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T11:15:36Z","timestamp":1680174936000},"page":"e235763","source":"Crossref","is-referenced-by-count":116,"title":["Prevalence and Characteristics Associated With Post\u2013COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults"],"prefix":"10.1001","volume":"6","author":[{"given":"Joel","family":"Selvakumar","sequence":"first","affiliation":[{"name":"Department of Paediatrics and Adolescent Health, Akershus University Hospital, L\u00f8renskog, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Beier","family":"Havdal","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Health, Akershus University Hospital, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Drevvatne","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Health, Akershus University Hospital, L\u00f8renskog, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias Myrstad","family":"Brodwall","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Health, Akershus University Hospital, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Lund Berven","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Health, Akershus University Hospital, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonje","family":"Stiansen-Sonerud","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Health, Akershus University Hospital, L\u00f8renskog, Norway"},{"name":"Department of Clinical Molecular Biology (EpiGen), University of Oslo and Akershus University Hospital, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Einvik","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"},{"name":"Department of Pulmonary Medicine, Akershus University Hospital, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truls Michael","family":"Leegaard","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"},{"name":"Department of Microbiology and Infection Control, Akershus University Hospital, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trygve","family":"Tjade","sequence":"additional","affiliation":[{"name":"F\u00fcrst Medical Laboratory, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika E.","family":"Michelsen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"},{"name":"Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Eirik","family":"Mollnes","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway"},{"name":"Research Laboratory, Nordland Hospital, Bod\u00f8, Norway"},{"name":"Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fridtjof","family":"Lund-Johansen","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trygve","family":"Holm\u00f8y","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"},{"name":"Department of Neurology, Akershus University Hospital, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"},{"name":"UCL Institute of Neurology, Department of Neurodegenerative Disease, London, United Kingdom"},{"name":"UK Dementia Research Institute, Gower Street, London, United Kingdom"},{"name":"Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, M\u00f6lndal, Sweden"},{"name":"Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina X.","family":"Sandler","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Western Sydney University, Penrith, Australia"},{"name":"The Kirby Institute, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Cvejic","sequence":"additional","affiliation":[{"name":"School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Lloyd","sequence":"additional","affiliation":[{"name":"The Kirby Institute, University of New South Wales, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vegard Bruun Bratholm","family":"Wyller","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Health, Akershus University Hospital, L\u00f8renskog, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"issue":"4","key":"zoi230195r1","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus.","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"zoi230195r2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/life12020285","article-title":"Long COVID in children and adolescents.","volume":"12","author":"Fainardi","year":"2022","journal-title":"Life (Basel)"},{"issue":"2","key":"zoi230195r3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jinf.2021.11.011","article-title":"Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies.","volume":"84","author":"Behnood","year":"2022","journal-title":"J Infect"},{"issue":"10","key":"zoi230195r4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab440","article-title":"Long COVID and post-infective fatigue syndrome: a review.","volume":"8","author":"Sandler","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"zoi230195r5","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1038\/s41467-022-32507-6","article-title":"A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.","volume":"13","author":"Kedor","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"zoi230195r6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/QCO.0000000000000854","article-title":"Long COVID in children and adolescents.","volume":"35","author":"Stephenson","year":"2022","journal-title":"Curr Opin Infect Dis"},{"key":"zoi230195r7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis.","volume":"101","author":"Ceban","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"10","key":"zoi230195r8","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/cid\/ciu629","article-title":"Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study.","volume":"59","author":"Hanevik","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7568","key":"zoi230195r9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study.","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"key":"zoi230195r10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbi.2018.09.023","article-title":"Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: a prospective cohort study.","volume":"75","author":"Pedersen","year":"2019","journal-title":"Brain Behav Immun"},{"issue":"9","key":"zoi230195r11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-005427","article-title":"Characterising long COVID: a living systematic review.","volume":"6","author":"Michelen","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"22","key":"zoi230195r12","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","article-title":"Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up.","volume":"169","author":"Lam","year":"2009","journal-title":"Arch Intern Med"},{"issue":"34","key":"zoi230195r13","doi-asserted-by":"publisher","first-page":"E7150","DOI":"10.1073\/pnas.1710519114","article-title":"Cytokine signature associated with disease severity in chronic fatigue syndrome patients.","volume":"114","author":"Montoya","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"zoi230195r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2020.101829","article-title":"Understanding persistent physical symptoms: conceptual integration of psychological expectation models and predictive processing accounts.","volume":"76","author":"Kube","year":"2020","journal-title":"Clin Psychol Rev"},{"key":"zoi230195r15","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1038\/s41591-022-02000-0","article-title":"Long-term cardiac pathology in individuals with mild initial COVID-19 illness.","volume":"28","author":"Puntmann","year":"2022","journal-title":"Nat Med"},{"issue":"10","key":"zoi230195r16","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1111\/jth.15490","article-title":"Persistent endotheliopathy in the pathogenesis of long COVID syndrome.","volume":"19","author":"Fogarty","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"3","key":"zoi230195r17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048391","article-title":"Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study.","volume":"11","author":"Dennis","year":"2021","journal-title":"BMJ Open"},{"issue":"21","key":"zoi230195r18","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","article-title":"The neurobiology of long COVID.","volume":"110","author":"Monje","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"zoi230195r19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41467-021-27797-1","article-title":"Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome.","volume":"13","author":"Cervia","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"zoi230195r22","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamapsychiatry.2022.2640","article-title":"Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions.","volume":"79","author":"Wang","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"zoi230195r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260061","article-title":"The impact of pandemic-related worry on cognitive functioning and risk-taking.","volume":"16","author":"da Silva Castanheira","year":"2021","journal-title":"PLoS One"},{"key":"zoi230195r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120487","article-title":"Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization.","volume":"443","author":"Frontera","year":"2022","journal-title":"J Neurol Sci"},{"issue":"12","key":"zoi230195r25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study.","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"issue":"5","key":"zoi230195r26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/INF.0000000000003502","article-title":"The challenge of studying long COVID: an updated review.","volume":"41","author":"Zimmermann","year":"2022","journal-title":"Pediatr Infect Dis J"},{"issue":"23","key":"zoi230195r27","doi-asserted-by":"publisher","first-page":"12595","DOI":"10.1073\/pnas.2006706117","article-title":"Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic.","volume":"117","author":"Raker","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"zoi230195r28","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S1473-3099(22)00449-2","article-title":"Persistence, prevalence, and polymorphism of sequelae after COVID-19 in unvaccinated, young adults of the Swiss Armed Forces: a longitudinal, cohort study (LoCoMo).","volume":"22","author":"Deuel","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"zoi230195r29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.837288","article-title":"Inflammatory markers, pulmonary function, and clinical symptoms in acute COVID-19 among non-hospitalized adolescents and young adults.","volume":"13","author":"Lund Berven","year":"2022","journal-title":"Front Immunol"},{"issue":"16","key":"zoi230195r30","doi-asserted-by":"publisher","first-page":"20147","DOI":"10.2807\/ese.17.16.20147-en","article-title":"The Norwegian immunisation register--SYSVAK.","volume":"17","author":"Trogstad","year":"2012","journal-title":"Euro Surveill"},{"issue":"4","key":"zoi230195r31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S2352-4642(22)00022-0","article-title":"Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.","volume":"6","author":"Stephenson","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"zoi230195r32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S2352-4642(22)00004-9","article-title":"Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.","volume":"6","author":"Kikkenborg Berg","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"1","key":"zoi230195r33","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1038\/s41598-022-06166-y","article-title":"Comparison of mental health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic.","volume":"12","author":"Blankenburg","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"zoi230195r34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamainternmed.2021.6454","article-title":"Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic.","volume":"182","author":"Matta","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"3","key":"zoi230195r35","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1542\/peds.2006-2231","article-title":"Incidence, prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents: a prospective community study.","volume":"119","author":"Rimes","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"zoi230195r36","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1186\/s12889-020-09109-2","article-title":"Symptoms in the general Norwegian adult population\u2014prevalence and associated factors.","volume":"20","author":"Krogstad","year":"2020","journal-title":"BMC Public Health"},{"issue":"10","key":"zoi230195r37","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S2215-0366(20)30308-4","article-title":"Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population.","volume":"7","author":"Pierce","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"zoi230195r38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S2215-0366(20)30570-8","article-title":"Child mental health in England before and during the COVID-19 lockdown.","volume":"8","author":"Newlove-Delgado","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"zoi230195r39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S2352-4642(21)00177-2","article-title":"Young people\u2019s mental health during the COVID-19 pandemic.","volume":"5","author":"Creswell","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"zoi230195r40","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID.","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat Med"},{"issue":"10","key":"zoi230195r41","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.cmi.2021.05.033","article-title":"Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.","volume":"27","author":"Peghin","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"8961","key":"zoi230195r42","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0140-6736(95)92537-6","article-title":"Postinfectious fatigue: prospective cohort study in primary care.","volume":"345","author":"Wessely","year":"1995","journal-title":"Lancet"},{"issue":"9","key":"zoi230195r43","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-021-01433-3","article-title":"Long COVID in a prospective cohort of home-isolated patients.","volume":"27","author":"Blomberg","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"zoi230195r44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0002-9343(00)00560-X","article-title":"Acute infectious mononucleosis: characteristics of patients who report failure to recover.","volume":"109","author":"Buchwald","year":"2000","journal-title":"Am J Med"},{"issue":"1","key":"zoi230195r45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2006.10.011","article-title":"Post-infectious fatigue syndrome in dengue infection.","volume":"38","author":"Seet","year":"2007","journal-title":"J Clin Virol"},{"issue":"10350","key":"zoi230195r46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","article-title":"Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.","volume":"400","author":"Ballering","year":"2022","journal-title":"Lancet"},{"issue":"10270","key":"zoi230195r47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"zoi230195r48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069676","article-title":"Trajectory of long covid symptoms after COVID-19 vaccination: community based cohort study.","volume":"377","author":"Ayoubkhani","year":"2022","journal-title":"BMJ"},{"issue":"11","key":"zoi230195r49","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S2213-2600(21)00383-0","article-title":"Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.","volume":"9","author":"Evans","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"zoi230195r50","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/S2213-2600(22)00501-X","article-title":"A new paradigm is needed to explain long COVID.","volume":"11","author":"Saunders","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"8","key":"zoi230195r51","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/cid\/cix013","article-title":"Effectiveness of long-term doxycycline treatment and cognitive-behavioral therapy on fatigue severity in patients with Q fever fatigue syndrome (Qure Study): a randomized controlled trial.","volume":"64","author":"Keijmel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"zoi230195r20","doi-asserted-by":"crossref","unstructured":"Bertran? M, Pinto Pereira? S, Nugawela? MD, . Association between parents experiencing ongoing problems from COVID-19 and adolescents reporting long COVID six months after a positive or negative SARS-CoV-2 PCR-test: prospective, national cohort study in England.? SSRN. Preprint posted August 14, 2022. doi:10.2139\/ssrn.4192732","DOI":"10.2139\/ssrn.4192732"},{"key":"zoi230195r21","doi-asserted-by":"crossref","unstructured":"Nugawela? MD, Stephenson? T, Shafran? R, . Developing a model for predicting impairing physical symptoms in children 3 months after a SARS-CoV-2 PCR-test: the CLoCk study.? medRxiv. Preprint posted April 5, 2022. doi:10.1101\/2022.04.01.22273117","DOI":"10.1101\/2022.04.01.22273117"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2802893\/selvakumar_2023_oi_230195_1679406259.62234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T11:15:42Z","timestamp":1680174942000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2802893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.5763","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]}}}